P38 kinase inhibiting agents

Details for Australian Patent Application No. 2006322033 (hide)

Owner Merck & Co., Inc.

Inventors Doherty, James B.; Tynebor, Robert; Chen, Meng-Hsin

Agent Spruson & Ferguson

Pub. Number AU-A-2006322033

PCT Pub. Number WO2007/067478

Priority 60/742,225 05.12.05 US

Filing date 1 December 2006

Wipo publication date 14 June 2007

International Classifications

C07D 455/02 (2006.01) Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine

A61K 31/4375 (2006.01)

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/067478 Priority application(s): WO2007/067478

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322035-Nitric oxide-releasing polymers

2006322030-Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry